Link: https://links.sgx.com/1.0.0/corporate-announcements/S6J06SQXUDFK7M2E/11f1cae4fdd1397bb9dec816d7931776a35552a17e536b1d7817c872569085f9

Summary:

• Revenue for 1H 2025: US$258.4 million, down US$99.3 million (27.8%) from 1H 2024 due to weaker global demand and lower average prices for chemical products.

• Loss before interest, tax, depreciation and amortization (LBITDA): US$0.5 million vs EBITDA of US$1.4 million last year.

• Net loss after tax: US$1.1 million (down US$1.6 million from a profit of US$0.5 million in 1H 2024).

• OSC Group business outlook remains stable for the next 12 months, barring major adverse changes in global conditions, chemical prices, or freight costs.

• Joint venture for FDME project (furan dicarboxylic methyl ester): JV agreement terminated; plans to revisit project when facility is ready.

• Sold 12.74% equity in Sunrise Group for RMB62 million (US$8.7 million); net proceeds after tax and duties approximately US$8.1 million, compared to original investment of RMB20 million.

• Company continues evaluating new chemical-related investments and possible exits to balance short- and long-term goals.